C-22 ring stabilized rapamycin derivatives

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 19/01 (2006.01) A61K 31/70 (2006.01) C07D 498/18 (2006.01) C07H 23/00 (2006.01)

Patent

CA 2169277

This invention provides C-22 substituted rapamycin derivatives of formulas (Ia) or (Ib) or a pharmaceutically acceptable salt thereof or a proline analogue thereof or a pharmaceutically acceptable salt of a proline analogue thereof which are useful for inducing immunosuppression and treating transplantation rejection, host vs. graft disease, autoimmune diseases, diseases of inflammation, solid tumors, fungal infections, adult T-cell leukemia/lymphomas and hyperproliferative vascular disorders.

L'invention porte sur des dérivés substitués en position C-22 de la rapamycine, de formule (Ia) ou (Ib), ou un de leurs sels pharmacocompatibles, ou une proline analogue, ou un sel pharmacocompatible de ladite proline. Ces produits se sont avérés utiles comme inducteurs d'immunosuppression et dans le traitement du rejet des transplants, des rejets de greffons, des affections autoimmumes, des maladies inflammatoires, des tumeurs nodulaires, des mycoses, des leucémies/lymphomes à cellules T de l'adulte, et de l'hyperprolifération vasculaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

C-22 ring stabilized rapamycin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with C-22 ring stabilized rapamycin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C-22 ring stabilized rapamycin derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1438796

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.